Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Cereb Cortex ; 24(6): 1518-28, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23349224

RESUMEN

The aim of the present study was to investigate the involvement of N-methyl-d-aspartate (NMDA) and amino-3-hydroxy-5-methyl-isoxazole-4-proprionate (AMPA)/kainate receptors of the prelimbic (PL) division of the medial prefrontal cortex (MPFC) on the panic attack-like reactions evoked by γ-aminobutyric acid-A receptor blockade in the medial hypothalamus (MH). Rats were pretreated with NaCl 0.9%, LY235959 (NMDA receptor antagonist), and NBQX (AMPA/kainate receptor antagonist) in the PL at 3 different concentrations. Ten minutes later, the MH was treated with bicuculline, and the defensive responses were recorded for 10 min. The antagonism of NMDA receptors in the PL decreased the frequency and duration of all defensive behaviors evoked by the stimulation of the MH and reduced the innate fear-induced antinociception. However, the pretreatment of the PL cortex with NBQX was able to decrease only part of defensive responses and innate fear-induced antinociception. The present findings suggest that the NMDA-glutamatergic system of the PL is critically involved in panic-like responses and innate fear-induced antinociception and those AMPA/kainate receptors are also recruited during the elaboration of fear-induced antinociception and in panic attack-related response. The activation of the glutamatergic neurotransmission of PL division of the MPFC during the elaboration of oriented behavioral reactions elicited by the chemical stimulation of the MH recruits mainly NMDA receptors in comparison with AMPA/kainate receptors.


Asunto(s)
Conducta Animal/fisiología , Miedo/fisiología , Hipotálamo Medio/fisiología , Percepción del Dolor/fisiología , Pánico/fisiología , Corteza Prefrontal/fisiología , Animales , Conducta Animal/efectos de los fármacos , Bicuculina/farmacología , Antagonistas de Aminoácidos Excitadores/farmacología , Miedo/efectos de los fármacos , Antagonistas de Receptores de GABA-A/farmacología , Hipotálamo Medio/efectos de los fármacos , Isoquinolinas/farmacología , Masculino , Dolor Nociceptivo/tratamiento farmacológico , Dolor Nociceptivo/fisiopatología , Percepción del Dolor/efectos de los fármacos , Pánico/efectos de los fármacos , Corteza Prefrontal/efectos de los fármacos , Quinoxalinas/farmacología , Ratas Wistar , Receptores AMPA/antagonistas & inhibidores , Receptores AMPA/metabolismo , Receptores de GABA-A/metabolismo , Receptores de N-Metil-D-Aspartato/antagonistas & inhibidores , Receptores de N-Metil-D-Aspartato/metabolismo , Transmisión Sináptica/efectos de los fármacos , Transmisión Sináptica/fisiología
2.
J Psychopharmacol ; 27(12): 1149-59, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23926240

RESUMEN

The potential anxiolytic and antipanic properties of cannabidiol have been shown; however, its mechanism of action seems to recruit other receptors than those involved in the endocannabinoid-mediated system. It was recently shown that the model of panic-like behaviors elicited by the encounters between mice and snakes is a good tool to investigate innate fear-related responses, and cannabidiol causes a panicolytic-like effect in this model. The aim of the present study was to investigate the 5-hydroxytryptamine (5-HT) co-participation in the panicolytic-like effects of cannabidiol on the innate fear-related behaviors evoked by a prey versus predator interaction-based paradigm. Male Swiss mice were treated with intraperitoneal (i.p.) administrations of cannabidiol (3 mg/kg, i.p.) and its vehicle and the effects of the peripheral pre-treatment with increasing doses of the 5-HT1A receptor antagonist WAY-100635 (0.1, 0.3 and 0.9 mg/kg, i.p.) on instinctive fear-induced responses evoked by the presence of a wild snake were evaluated. The present results showed that the panicolytic-like effects of cannabidiol were blocked by the pre-treatment with WAY-100635 at different doses. These findings demonstrate that cannabidiol modulates the defensive behaviors evoked by the presence of threatening stimuli, and the effects of cannabidiol are at least partially dependent on the recruitment of 5-HT1A receptors.


Asunto(s)
Cannabidiol/farmacología , Pánico/efectos de los fármacos , Receptor de Serotonina 5-HT1A/metabolismo , Animales , Ansiolíticos/farmacología , Conducta Animal/efectos de los fármacos , Boidae , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Miedo/efectos de los fármacos , Inyecciones Intraperitoneales , Masculino , Ratones , Trastorno de Pánico/tratamiento farmacológico , Piperazinas/administración & dosificación , Piperazinas/farmacología , Conducta Predatoria , Piridinas/administración & dosificación , Piridinas/farmacología , Receptor de Serotonina 5-HT1A/efectos de los fármacos , Antagonistas de la Serotonina/administración & dosificación , Antagonistas de la Serotonina/farmacología
3.
Int J Neuropsychopharmacol ; 16(8): 1781-98, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23521775

RESUMEN

It has been shown that GABAA receptor blockade in the dorsomedial and ventromedial hypothalamic nuclei (DMH and VMH, respectively) induces elaborated defensive behavioural responses accompanied by antinociception, which has been utilized as an experimental model of panic attack. Furthermore, the prelimbic (PL) division of the medial prefrontal cortex (MPFC) has been related to emotional reactions and the processing of nociceptive information. The aim of the present study was to investigate the possible involvement of the PL cortex and the participation of local cannabinoid CB1 receptors in the elaboration of panic-like reactions and in innate fear-induced antinociception. Elaborated fear-induced responses were analysed during a 10-min period in an open-field test arena. Microinjection of the GABAA receptor antagonist bicuculline into the DMH/VMH evoked panic-like behaviour and fear-induced antinociception, which was decreased by microinjection of the non-selective synaptic contact blocker cobalt chloride in the PL cortex. Moreover, microinjection of AM251 (25, 100 or 400 pmol), an endocannabinoid CB1 receptor antagonist, into the PL cortex also attenuated the defensive behavioural responses and the antinociception that follows innate fear behaviour elaborated by DMH/VMH. These data suggest that the PL cortex plays an important role in the organization of elaborated forward escape behaviour and that this cortical area is also involved in the elaboration of innate fear-induced antinociception. Additionally, CB1 receptors in the PL cortex modulate both panic-like behaviours and fear-induced antinociception elicited by disinhibition of the DMH/VMH through microinjection of bicuculline.


Asunto(s)
Mecanismos de Defensa , Hipotálamo/efectos de los fármacos , Dimensión del Dolor/efectos de los fármacos , Pánico/efectos de los fármacos , Corteza Prefrontal/fisiopatología , Receptor Cannabinoide CB1/metabolismo , Receptores de GABA-A/metabolismo , Análisis de Varianza , Animales , Bicuculina/farmacología , Bicuculina/uso terapéutico , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Antagonistas del GABA/farmacología , Antagonistas del GABA/uso terapéutico , Hiperalgesia/tratamiento farmacológico , Hiperalgesia/patología , Hipotálamo/fisiología , Instinto , Masculino , Microinyecciones , Umbral del Dolor/efectos de los fármacos , Piperidinas/farmacología , Corteza Prefrontal/efectos de los fármacos , Pirazoles/farmacología , Ratas , Ratas Wistar , Receptor Cannabinoide CB1/antagonistas & inhibidores
4.
Neuropsychopharmacology ; 37(2): 412-21, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21918503

RESUMEN

Several pharmacological targets have been proposed as modulators of panic-like reactions. However, interest should be given to other potential therapeutic neurochemical agents. Recent attention has been given to the potential anxiolytic properties of cannabidiol, because of its complex actions on the endocannabinoid system together with its effects on other neurotransmitter systems. The aim of this study was to investigate the effects of cannabidiol on innate fear-related behaviors evoked by a prey vs predator paradigm. Male Swiss mice were submitted to habituation in an arena containing a burrow and subsequently pre-treated with intraperitoneal administrations of vehicle or cannabidiol. A constrictor snake was placed inside the arena, and defensive and non-defensive behaviors were recorded. Cannabidiol caused a clear anti-aversive effect, decreasing explosive escape and defensive immobility behaviors outside and inside the burrow. These results show that cannabidiol modulates defensive behaviors evoked by the presence of threatening stimuli, even in a potentially safe environment following a fear response, suggesting a panicolytic effect.


Asunto(s)
Cannabidiol/farmacología , Modelos Animales de Enfermedad , Miedo/efectos de los fármacos , Instinto , Trastorno de Pánico/tratamiento farmacológico , Animales , Ansiolíticos/farmacología , Ansiolíticos/uso terapéutico , Cannabidiol/uso terapéutico , Humanos , Masculino , Ratones , Serpientes
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...